Home › Kanser sa Baga › Kansas › Kansas City

Pag-aaral pangklinika para sa Kanser sa Baga sa Kansas City, KS

Isang pag-aaral para sa Kanser sa Baga ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Kansas City. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo

Veteran Administration Eastern Kansas Healthcare, Leavenworth · 21 mi ang layo

Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05334069

Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer

Nagre-recruitPhase 1/2

University of Kansas Cancer Center, Kansas City

Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT06287775

Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

Nagre-recruitPhase 1

University of Kansas Medical Center, Kansas City

Edad 18 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06343402

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

Nagre-recruitPhase 3

University of Kansas Cancer Center, Kansas City

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT05624996

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

Nagre-recruitPhase 3

University of Kansas Cancer Center, Kansas City

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT06500481

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Nagre-recruitPhase 1/2

The University of Kansas Cancer Center, Kansas City

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 11, 2026 · NCT05592626

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Nagre-recruitPhase 2

University of Kansas Cancer Center, Kansas City

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 3, 2026 · NCT05642572

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Nagre-recruitPhase 2/3

University of Kansas Cancer Center, Kansas City
Veteran Administration Eastern Kansas Healthcare, Leavenworth · 21 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update May 5, 2026 · NCT06616584

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Nagre-recruitPhase 2

University of Kansas Cancer Center, Kansas City

18 Minutes · Lahat ng kasarian · Na-update May 5, 2026 · NCT06031688

Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier

Nagre-recruitObservasyonal na pag-aaral

University of Kansas Medical Center, Kansas City

Edad 29 hanggang 85 · Lahat ng kasarian · Na-update Nob 13, 2024 · NCT06426628

Using Ex Vivo Tumoroids To Predict Immunotherapy Response In NSCLC

Nagre-recruitObservasyonal na pag-aaral

The University of Kansas Cancer Center, Westwood Campus, Kansas City

Edad 18 hanggang 110 · Lahat ng kasarian · Na-update Peb 23, 2024 · NCT05332925

Pag-aaral para sa Kanser sa Baga sa ibang lungsod

Iba pang pag-aaral sa Kansas City

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.